BeStock  
Stocks › Biotechnology › ZLAB

Zai Lab ZLAB

US equityMarket cap rank #2582BiotechnologyChina Concept Stocks
$21.03 −$0.89 (-4.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $21.03 0.00%
Open$20.99
Prev close$21.92
Day range$20.02 – $21.15
Volume1.44M
Market cap$2.36B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$108.21M-6.8% YoY
Operating profit-$62.98M-29.0% YoY
Net profit-$46.14M-28.3% YoY
Diluted EPS-$0.40-33.3% YoY
Free cash flow-$70.77M-95.9% YoY
Operating cash flow-$57.87M

Revenue, last 8 quarters

$109.1MDec '24$106.5MMar '25$110.0MJun '25$116.1MSep '25$127.6MDec '25$99.6MMar '26$106.3MJun '26$108.2MSep '26

Net profit, last 8 quarters

$-81.7MDec '24$-48.4MMar '25$-40.7MJun '25$-36.0MSep '25$-50.4MDec '25$-51.0MMar '26$-50.8MJun '26$-46.1MSep '26

Diluted EPS by quarter

-0.80Dec '24-0.40Mar '25-0.40Jun '25-0.30Sep '25-0.50Dec '25-0.50Mar '26-0.50Jun '26-0.40Sep '26

Free cash flow by quarter

$-73.5MDec '24$-65.6MMar '25$-35.2MJun '25$-36.1MSep '25$-27.3MDec '25$-34.2MMar '26$-64.9MJun '26$-70.8MSep '26

Annual revenue

$49.0MFY20$144.3MFY21$215.0MFY22$266.7MFY23$399.0MFY24$460.2MFY25

Profitability & balance sheet

Gross margin54.7%
Operating margin-61.7%
Net margin-44.9%
Return on equity-30.0%
Return on assets-18.2%
Return on invested capital-24.0%
Current ratio2.04
Liabilities / assets45.0%
Cash & investments$559.66M
Total debt$261.92M
Net cash (debt)$297.74M

Where the revenue comes from

Quarter 2026/Q3

By business line

  • ZEJULA$32.28M 29.8%
  • VYVGART / VYVGART Hytrulo$24.07M 22.2%
  • NUZYRA$21.09M 19.5%
  • QINLOCK$8.83M 8.2%
  • XACDURO$8.42M 7.8%
  • Optune$7.82M 7.2%
  • AUGTYRO$2.82M 2.6%
  • KarXT$2.02M 1.9%
  • Collaboration revenue$560,000.00 0.5%
  • Other$296,000.00 0.3%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $108.21M $106.31M $99.61M $460.16M $127.60M
Total Operating Revenue $108.21M $106.31M $99.61M $460.16M $127.60M
Cost of Revenue $51.31M $48.16M $38.34M $191.08M $62.33M
Gross Profit $56.90M $58.15M $61.28M $269.08M $65.27M
Operating Expense $119.88M $134.64M $130.56M $492.65M $128.81M
Selling and Admin Expenses $70.07M $72.87M $65.07M $277.61M $73.04M
-General & Admin Expense $70.07M $72.87M $65.07M $277.61M $73.04M
Research & Development $49.81M $61.77M $65.59M $220.90M $61.63M
Operating Profit -$62.98M -$76.49M -$69.28M -$223.57M -$63.54M
Net Non-Operating Interest Income (Expense) $4.15M $4.29M $4.81M $27.84M $5.89M
Non-Operating Interest Income $5.73M $5.88M $6.45M $33.05M $7.25M
Non-Operating Interest Expense $1.58M $1.59M $1.64M $5.21M $1.36M
Other Income (Expense) $10.82M $20.35M $14.89M $17.27M $4.32M
Gain on Sale of Security $10.53M $15.07M $14.84M $19.59M $9.68M
Other Non-Operating Income (Expenses) $288,000.00 $5.29M $56,000.00 -$410,000.00 -$3.46M
Pretax Profit -$48.01M -$51.85M -$49.58M -$178.46M -$53.34M
Tax -$1.87M -$1.02M $1.44M -$2.93M -$2.93M
Net Profit -$46.14M -$50.83M -$51.02M -$175.54M -$50.41M
Profit from Continuing Operations -$46.14M -$50.83M -$51.02M -$175.54M -$50.41M
Net Income to Parent Company -$46.14M -$50.83M -$51.02M -$175.54M -$50.41M
Net Income to Common Stockholders -$46.14M -$50.83M -$51.02M -$175.54M -$50.41M
Basic EPS -$0.40 -$0.50 -$0.50 -$1.60 -$0.50
Diluted EPS -$0.40 -$0.50 -$0.50 -$1.60 -$0.50
Other Operating Expenses – – -$106,000.00 -$5.86M -$1.14M
Earnings from Equity Interest – – $0.00 -$1.91M $0.00
Special Income (Charges) – – – $0.00 –
-Gain on Sale of Property/Plant/Equipment – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.02B $1.07B $1.10B $1.17B $1.17B
Total Current Assets $864.40M $914.04M $944.73M $1.02B $1.02B
Cash and Cash Equivalents & Short-Term Investments $559.66M $617.52M $661.32M $689.57M $689.57M
-Cash and Cash Equivalents $549.66M $607.52M $651.32M $679.57M $679.57M
-Short Term Investments $10.00M $10.00M $10.00M $10.00M $10.00M
Receivables $75.40M $72.99M $62.00M $118.29M $118.29M
-Accounts Receivable $65.30M $69.60M $54.07M $106.12M $106.12M
-Notes Receivable $10.10M $3.40M $7.93M $12.17M $12.17M
Inventory $85.29M $90.89M $85.96M $74.75M $74.75M
Restricted Cash $100.00M $100.00M $100.00M $100.00M $100.00M
Other Current Assets $44.05M $32.64M $35.45M $36.68M $36.68M
Total Non-Current Assets $159.50M $160.76M $151.01M $153.10M $153.10M
Net PPE $60.98M $62.59M $64.65M $66.54M $66.54M
-Gross PPE $110.80M $109.75M $109.30M $108.70M $108.70M
-Accumulated Depreciation -$49.82M -$47.16M -$44.65M -$42.16M -$42.16M
Goodwill and Other Intangible Assets $88.18M $88.66M $78.63M $79.00M $79.00M
-Other Intangible Assets $88.18M $88.66M $78.63M $79.00M $79.00M
Non-Current Deferred Assets $6.48M $4.85M $3.44M $3.39M $3.39M
Other Non-Current Assets $3.86M $4.66M $4.29M $4.17M $4.17M
Total Liabilities $460.62M $467.76M $433.76M $456.88M $456.88M
Total Current Liabilities $424.25M $428.58M $392.98M $416.17M $416.17M
Payables $124.61M $141.11M $130.46M $147.40M $147.40M
-Accounts Payable $120.25M $136.69M $126.17M $141.61M $141.61M
-Total Tax Payable $3.47M $4.02M $3.66M $5.30M $5.30M
-Other Payable $895,000.00 $402,000.00 $629,000.00 $486,000.00 $486,000.00
Current Accrued Expenses $38.39M $41.52M $36.23M $50.82M $50.82M
Short-Term Debt and Capital Lease Obligation $257.89M $243.13M $219.80M $210.87M $210.87M
-Current Debt $252.37M $238.10M $213.82M $204.53M $204.53M
-Current Capital Lease Obligation $5.53M $5.03M $5.98M $6.34M $6.34M
Other Current Liabilities $3.35M $2.82M $6.49M $7.07M $7.07M
Total Non-Current Liabilities $36.37M $39.17M $40.77M $40.72M $40.72M
Long Term Debt and Capital Lease Obligation $9.56M $11.45M $12.11M $13.39M $13.39M
-Long Term Capital Lease Obligation $9.56M $11.45M $12.11M $13.39M $13.39M
Non-Current Deferred Liabilities $26.24M $27.50M $28.63M $27.33M $27.33M
Other Non-Current Liabilities $570,000.00 $225,000.00 $40,000.00 – –
Total Equity $563.28M $607.04M $661.98M $715.50M $715.50M
Stockholders' Equity $563.28M $607.04M $661.98M $715.50M $715.50M
Capital Stock $7,000.00 $7,000.00 $7,000.00 $7,000.00 $7,000.00
-Common Stock $7,000.00 $7,000.00 $7,000.00 $7,000.00 $7,000.00
Additional Paid-In Capital $3.38B $3.37B $3.36B $3.34B $3.34B
Retained Earnings -$2.78B -$2.73B -$2.68B -$2.63B -$2.63B
Less: Treasury Stock -$33.76M -$33.52M -$31.32M -$29.05M -$29.05M
Gains/Losses Not Affecting Retained Earnings -$10.86M $214,000.00 $15.11M $29.70M $29.70M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$57.87M -$63.41M -$11.91M -$150.79M -$26.02M
Net cash flow from continuing operations -$57.87M -$63.41M -$11.91M -$150.79M -$26.02M
Net Income from Continuing Operations -$46.14M -$50.83M -$51.02M -$175.54M -$50.41M
Gain/Loss from Continuing Operations -$10.51M -$15.05M -$14.82M -$19.05M -$9.38M
Depreciation & Depletion & Amortization $4.41M $4.17M $3.94M $15.01M $3.92M
Other Non-Cash Items -$54,000.00 $201,000.00 $417,000.00 $3.69M $238,000.00
Change in Working Capital -$24.11M -$19.74M $35.87M -$54.71M $2.33M
-Change in Receivables -$3.19M -$10.96M $57.68M -$29.98M -$15.49M
-Change in Inventory $1.67M -$10.62M -$11.21M -$47.03M -$18.92M
-Change in Prepaid Assets -$11.27M $3.20M $1.52M $5.06M $6.85M
-Change in Payables and Accrued Expense -$6.10M -$1.38M $4.26M $19.93M $20.35M
-Change in Other Current Assets $807,000.00 – – – –
-Change in Other Current Liabilities -$6.02M $337,000.00 -$18.66M -$3.05M $10.12M
-Change In Other Working Capital -$4,000.00 $89,000.00 $2.28M $371,000.00 $10,000.00
Net cash flow from investing -$12.68M -$1.42M -$22.29M $307.87M -$11.30M
Net Cash Flow from Continuing Investing Activities -$12.68M -$1.42M -$22.29M $307.87M -$11.30M
Net PPE Purchase and Sale -$722,000.00 -$1.27M -$1.19M -$8.01M -$675,000.00
Net Intangibles Purchase and Sale -$11.96M -$151,000.00 -$21.10M -$5.32M -$621,000.00
Net Investment Purchase and Sale $0.00 $0.00 $0.00 $321.20M -$10.00M
Financing Cash Flow $14.05M $18.71M $5.57M $72.35M -$430,000.00
Net Cash Flow from Continuing Financing Activities $14.05M $18.71M $5.57M $72.35M -$430,000.00
Net Issuance Payments Of Debt $11.53M $19.96M $7.01M $67.94M -$679,000.00
Proceeds from Stock Option Exercised $2.75M $946,000.00 $833,000.00 $13.68M $249,000.00
Net Other Financing Charges -$229,000.00 -$2.20M -$2.27M -$9.27M $0.00
Ending Cash Balance $650.78M $708.64M $752.43M $780.69M $780.69M
Net Change in Cash -$56.50M -$46.12M -$28.63M $229.43M -$37.75M
Beginning Cash Balance $708.64M $752.43M $780.69M $550.78M $818.27M
Effect of Exchange Rate Changes -$1.37M $2.33M $371,000.00 $478,000.00 $167,000.00
Free Cash Flow -$70.77M -$64.87M -$34.20M -$164.21M -$27.32M
Net Common Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on ZLAB.

Sign in to join the discussion.

Scroll to Top